Related Articles
Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer
Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer
Quantitative detection of TUSC3 promoter methylation - a potential biomarker for prognosis in lung cancer
Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers
Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer